Clinical Trials Logo

PULSE WAVE VELOCITY clinical trials

View clinical trials related to PULSE WAVE VELOCITY.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT03918005 Not yet recruiting - Obesity Clinical Trials

Effects of Hypocaloric Diets With Different Glycemic Loads on Pulse Wave Velocity

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Worldwide, in terms of attributable deaths, the main intermediate risk factor for the development of cardiovascular diseases is systemic arterial hypertension, followed by overweight and sustained hyperglycemia. These factors have positively influenced public and private spending on health. The more robust studies showed that age is one of the main determinants of arterial stiffness. However, there is a possibility that other variables, such as elevated glucose levels, obesity, and systemic inflammation itself, as well as insulin resistance are important factors in this scenario. On the other hand, the measurement of the pulse wave velocity is widely acceptable for the evaluation of the arterial stiffness, inferring the cardiovascular risk in different populations. Since arterial stiffness is influenced by hemodynamic forces and inflammatory mediators, which may be related to sodium and glucose balance, it is necessary to evaluate whether a hypocaloric and low glycemic load diet, in a thesis that decreases lipid and inflammatory levels, may have favorable effects on pulse wave velocity in overweight adults.